Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Pulmonary Arterial Hypertension
Trial Information
Scleroderma and Pulmonary Hypertension (PHT) - Adults
People with scleroderma and early PHT are asked to participate
in a research study being conducted by North Shore-LIJ Health
System.
You may be eligible to participate in this study if
you:
- Are at least 18 years of age
- Have been diagnosis with scleroderma and pulmonary
hypertension
You may not participate in this study if
you:
- Have been previously diagnosed with PHT and treated for more
than 6 months
- Have severe interstitial lung disease (a variety of diseases
involving the lung tissue),
- Pulmonary thrombotic disease (blood clots in the lung),
- Heart failure (heart loses its ability to efficiently pump
blood throughout the body),
- Cardiomyopathy (disease of the heart muscle),
- History of coronary artery disease(A narrowing or blockage of
the coronary arteries) or
- Other cardio-pulmonary problems (Relating to the heart and
lungs.)
Michelle Kong, Study Coordinator
Biomedical Research Alliance of New York
NS-LIJ Health Systems
Division of Rheumatology & Allergy-Clinical Immunology
2800 Marcus Ave, Suite 200
Lake Success, NY 11042
Phone: 516-708-2557
Fax: 516-708-2574
EMail: mkong@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
